Latest Breaking News On - டேவிட் கிளேர் - Page 5 : vimarsana.com

Bio-Techne and 908 Devices Announce Joint Collaboration

Share this article Share this article MINNEAPOLIS and BOSTON, May 4, 2021 /PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) and 908 Devices (NASDAQ: MASS) today announced a joint collaboration to develop an extended workflow solution for protein characterization. Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and owner of the leading ProteinSimple branded protein analysis portfolio of products, will pair its Maurice icIEF separation instrument with 908 Devices ZipChip device to deliver a seamless workflow for deeper protein characterization. Maurice and the iCE technology are the gold standard in protein characterization, providing absorbance and native fluorescence icIEF detection as well as CE-SDS, saving significant development time and reducing the time to commercialization.

United statesDave eansorCarrie mendivilKevinj knoppDavid clairEmily fangCorporate developmentBio techne protein sciences segmentThermo fisherBio techne corporationCapillary electrophoresisProtein sciencesTechne corporationRelations contactSenior directorInvestor relations

Bio-Techne Announces Commercial Release of Novel DNAscope™ in situ Hybridization Assays for Chromogenic Detection of DNA Copy Number and Structural Variations

MINNEAPOLIS, April 27, 2021 /PRNewswire/ Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD), a Bio-Techne brand, RNAscopeâ¢ technology with release of new DNAscope Assays. The RNAscope technology is an advanced in situ hybridization (ISH) assay that enables visualization of single-molecule gene expression with single-cell resolution directly in intact cells and tissues. Bio-Techne s new chromogenic DNA in situ hybridization (ISH) technology, DNAscope, employs the proven double-Z probe design and signal amplification system of RNAscope, enabling rapid and flexible probe development for any DNA target, enabling visualization of targets in formalin-fixed paraffin-embedded (FFPE) tissues. DNAscope delivers benefits over current commercial FISH techniques that fall short on morphological detail due to the use of fluorescent nuclear staining and rely on high-resolution microscopes to visualize gene rearrangement and copy n

Kim keldermanDavid clairPrnewswire bio techne corporationResearch useCorporate developmentBio techne corporationTechne corporationAdvanced cell diagnosticsBacterial artificial chromosomeSenior directorInvestor relationsகிம் கேள்தேர்மன்டேவிட் கிளேர்ஆராய்ச்சி பயன்பாடுபெருநிறுவன வளர்ச்சிஉயிர் தொழில்நுட்பம் நிறுவனம்

Bio-Techne Announces Launch of Professional Assay Services - Dedicated Source for RNA in situ Hybridization Assays in Spatial Gene Expression Analysis

MINNEAPOLIS, April 15, 2021 /PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne brand, completed an extensive rebranding effort in response to increased demand for its Assay Services offered at its Newark, CA laboratory. At the heart of this re-launch is a name change from Pharma Assay Services to Professional Assay Services, with an expansion of offerings to global academic and clinical institutions, building on 10 years of experience providing services to our global pharma and biotech partners. Bio-Techne s Professional Assay Services provide in situ hybridization (ISH) gene expression analysis for target discovery, biomarker validation, drug safety assessment, and assay prototype development directly from the RNAscopeâ¢ technology experts.

Kim keldermanDavid clairPrnewswire bio techne corporationAssay servicesInvestor relations corporate developmentGood clinical laboratory practicesWorld health organizationPharma assay services to professionalBio techne corporationTechne corporationAdvanced cell diagnosticsPharma assay servicesProfessional assay servicesWorld healthSenior directorInvestor relations

Bio-Techne Announces Launch of Professional Assay Services - Dedicated Source for RNA in situ Hybridization Assays in Spatial Gene Expression Analysis

Bio-Techne Announces Launch of Professional Assay Services - Dedicated Source for RNA in situ Hybridization Assays in Spatial Gene Expression Analysis
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Kim keldermanDavid clairPrnewswire bio techne corporationAssay servicesInvestor relations corporate developmentGood clinical laboratory practicesWorld health organizationPharma assay services to professionalBio techne corporationTechne corporationAdvanced cell diagnosticsPharma assay servicesProfessional assay servicesWorld healthSenior directorInvestor relations